BMC Cancer
(Feb 2007)
A proof-of-principle study of epigenetic therapy with hydralazine and magnesium valproate plus doxorubicin cyclophosphamide as neoadjuvant therapy for locally advanced breast cancer
Dueñas-Gonzalez Alfonso,
Robles Elizabeth,
Camargo Maria F,
Candelaria Myrna,
Vela Teresa,
Ramirez Teresa,
Villarreal Patricia,
Bargallo Enrique,
Taja-Chayeb Lucia,
Perez-Cardenas Enrique,
Trejo-Becerril Catalina,
Chavez-Blanco Alma,
Revilla-Vazquez Alma,
de la Cruz-Hernandez Erik,
Gonzalez-Fierro Aurora,
Arce Claudia,
Perez-Plasencia Carlos
Affiliations
Dueñas-Gonzalez Alfonso
Robles Elizabeth
Camargo Maria F
Candelaria Myrna
Vela Teresa
Ramirez Teresa
Villarreal Patricia
Bargallo Enrique
Taja-Chayeb Lucia
Perez-Cardenas Enrique
Trejo-Becerril Catalina
Chavez-Blanco Alma
Revilla-Vazquez Alma
de la Cruz-Hernandez Erik
Gonzalez-Fierro Aurora
Arce Claudia
Perez-Plasencia Carlos
DOI
https://doi.org/10.1186/1471-2407-7-S1-A23
Journal volume & issue
Vol. 7,
no. Suppl 1
p.
A23
Published in BMC Cancer
ISSN
1471-2407 (Online)
Publisher
BMC
Country of publisher
United Kingdom
LCC subjects
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website
http://bmccancer.biomedcentral.com
About the journal
WeChat QR code
Close